Skip to content

A cross-sectional study investigating non-psychiatric comorbidities in adults with ADHD using the Japanese health insurance claims database

A study describing the prevalence of non-psychiatric disorders in adult ADHD patients and conducting comparison with a control population: a cross-sectional study using the Japanese health insurance claims database - A study describing the prevalence of non-psychiatric disorders in Japanese adult ADHD patients and conducting comparison with a control population

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000049401
Enrollment
1200000
Registered
2022-11-02
Start date
2022-11-02
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Attention deficit / hyperactivity disorder (ADHD)

Interventions

None listed

Sponsors

Shionogi & Co., Ltd.
Lead Sponsor
Takeda Pharmaceutical Company Limited.
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) 18 years or older at the end of October 2020. 2) The observation start date is before October 2020. 3) The observation end date is September 2021 or after.

Exclusion criteria

Exclusion criteria: No criteria

Design outcomes

Primary

MeasureTime frame
Prevalence and odds ratios for type 2 diabetes mellitus, diabetic complications, hypertension, cardiovascular disease, dyslipidemia, gout/hyperuricemia, chronic obstructive pulmonary disease (COPD), nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH), atopic dermatitis, injury, upper respiratory infection, and low back pain

Countries

Japan

Contacts

Public ContactYoshikazu Ishimoto

Shionogi & Co., Ltd. Medical Affairs Department

yoshikazu.ishimoto@shionogi.co.jp090-6916-8097

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026